• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Overview of the microbiota in the gut-liver axis in viral B and C hepatitis

    2021-12-03 06:15:22MariaAdrianaNeagAndreiOttoMitreAdrianCatineanAncaDanaBuzoianu
    World Journal of Gastroenterology 2021年43期

    Maria Adriana Neag, Andrei Otto Mitre, Adrian Catinean, Anca Dana Buzoianu

    Abstract Viral B and C hepatitis are a major current health issue, both diseases having a chronic damaging effect on the liver and its functions. Chronic liver disease can lead to even more severe and life-threatening conditions, such as liver cirrhosis and hepatocellular carcinoma. Recent years have uncovered an important interplay between the liver and the gut microbiome: the gut-liver axis. Hepatitis B and C infections often cause alterations in the gut microbiota by lowering the levels of ‘protective’ gut microorganisms and, by doing so, hinder the microbiota ability to boost the immune response. Treatments aimed at restoring the gut microbiota balance may provide a valuable addition to current practice therapies and may help limit the chronic changes observed in the liver of hepatitis B and C patients. This review aims to summarize the current knowledge on the anatofunctional axis between the gut and liver and to highlight the influence that hepatitis B and C viruses have on the microbiota balance, as well as the influence of treatments aimed at restoring the gut microbiota on infected livers and disease progression.

    Key Words: Viral B hepatitis; Viral C hepatitis; Gut-liver axis; Immunomodulation;Lipopolysaccharides; Short-chain fatty acids

    INTRODUCTION

    Viral B and C hepatitis are two types of infections with a high rate of morbidity and mortality[1]. Hepatitis B virus (HBV) is a DNA virus belonging to the Hepadna virus,and hepatitis C virus (HCV) is an RNA virus in the Flaviviridae family. These viruses have hepatic tropism, are non-cytopathic with the ability to cause chronic liver inflammation and even liver cirrhosis and hepatocellular carcinoma[2].

    Both HBV and HCV may cause similar clinical manifestations. Some patients may be asymptomatic, while others may have mild signs and symptoms from general manifestations (fatigue, fever, loss of appetite) to gastrointestinal symptoms(abdominal pain, nausea, vomiting, jaundice)[3].

    The microbiota represents the totality of microbes (bacteria, viruses, fungi,protozoans, and archaea) associated with the human microorganism, while the microbiome consists of all microbes and their genes[4]. The main part of the body colonized by microbes is the gastrointestinal tract, whereas other parts such as skin,airways, vaginal tract,etc.are also colonized, but to a lesser extent. Changes in the microbiota are continuous throughout our life and there are many influencing factors,from type of delivery and breastfeeding, to long-term dietary changes, frequent and prolonged antibiotic treatment or other medications,etc.[5]. There are six bacterial dominant phyla in the gut microbiota:FirmicutesandBacteroidetes(90 %),Proteobacteria,Actinobacteria,FusobacteriaandVerrucomicrobia[6]. The intestinal microbiota is a cornerstone in maintaining the homeostasis of the human body. Firstly, this"organ" provides nutrients and energy from ingested food and, secondly, it is able to produce important metabolites that play a role in maintaining the host's metabolism[7].

    The liver can be considered the largest immune organ in the body with a high ability to select and activate immune cells in response to metabolic products in the gut or to signals sent by various pathogens[8]. Recent years have seen advances in our understanding of the human microbiome and its interaction with us as hosts. The gutliver axis is part of these new discoveries, integrating the microbiome modifications and dysbiosis in hepatic pathologies.

    Our review will discuss part of the mechanisms by which the microbiome influences host immunity, as well as the gut-liver axis, with an accent on viral hepatitis B and C.

    MICROBIOTA AND THE IMMUNE SYSTEM

    Through its products, the human microbiota can influence both the local, enteric, and the systemic immune system, dysbiosis being correlated with several autoimmune,metabolic and neurodegenerative diseases (inflammatory bowel disease progression,rheumatoid arthritis, diabetes, asthma and bones homeostasis)[9 -15]. This shows that the microbiota is not only involved in intestinal, but also in systemic and organ specific pathologies. This relationship is bidirectional; systemic modifications can trigger intestinal changes, but also intestinal dysbiosis can trigger and maintain organ dysfunctions. Gut-associated lymphoid tissue (GALT) is an important "immunological organ" of the body that belongs to the gut-mucosal immune system. GALT consists of Peyer's patches, intraepithelial lymphocytes, lamina propria lymphocytes (including dendritic cells) and mesenteric lymph nodes. Activation of this system has the ability to produce various mediators with immunostimulatory or immunosuppressive effect[16].

    Some of the products by which the intestinal microflora communicates with the rest of our organism are lipopolysaccharides (LPS), bacterial DNA and RNA, flagellin,short-chain fatty acids (SCFA) such as acetate, propionate and butyrate, tryptophan(Trp) and it’s metabolites, teichoic acid and peptidoglycans and secondary bile acids(BA)[9 ,17]. These bacterial components and products of the bacterial metabolism are recognized by pattern recognition receptors, which particularly include the toll-like receptors (TLR) family. TLRs are expressed on epithelial and immune cells and are capable of recognizing specific bacterial molecules, triggering specific local protective and immunomodulatory (both pro- and anti-inflammatory) responses[18 ,19]. TLR activation is an essential element of the innate immune systems fight against the HBV and HCV infections[20 ,21]. Not all of these pathways were studied directly in connection with HBV and HCV. Therefore, more studies are needed to determine the exact relationship between the bacterial products, the immune system and hepatitis.

    We will briefly mention some of the most important of the microbial-produced products and their interaction with the immune system (Figure 1 ).

    LPS

    In Gram-negative bacteria, LPS are an important pathogen-associated molecular pattern and a well-studied microbial marker in connection with bacterial translocation and host systemic responses[22 ,23]. The outer membrane of gram-negative bacteria consists of LPS, which possess a hydrophobic endotoxin, called lipid A[24]. This component is recognized by TLR4 andviathis mechanism it further activates nuclear factor kappa B (NF-κB) and elicits pro-inflammatory effects[25 ,26]. One type of LPS isEscherichia coli(E. coli) produced LPS. This stimulates TLR4 receptors and triggers the release of pro-inflammatory cytokines.E.coliLPS also increases endotoxin tolerance and decreases the autoimmune activity, protecting against autoimmune diabetes[27].However, some bacterial species produce LPS molecules with underacylated lipid A that exhibit an immuno-inhibitory effect[28]. These LPS molecules are produced especially by members of theBacteroidalesorder and instead of stimulating TLR receptors, they silence the TLR4 signaling and the inflammatory process[29]. LPS induces the upregulation of cluster of differentiation 14 protein (CD14 ) via the TLR4 pathway, which decreases the relative epithelial resistance and increases its permeability. Increased intestinal permeability allows for more LPS to reach the general circulation, aiding it in reaching different organs and exhibiting a pro-inflammatory effect[30]. This is also true in cases of dysbiosis with an increase in LPS production that is correlated with an increase in tumor necrosis factor alpha (TNF-α),interleukin (IL) 6 and C-reactive protein levels[31 ,32]. Intestinal dysbiosis caused an LPS-induced inflammatory response in a mice model, while unaltered host microbiota reduced the inflammatory response to LPS in the liver[33]. LPS-induced monocyte activation has been shown to be increased in patients with HBV or HCV[34].

    This underlines the ability of LPS and gut lipid metabolism to modulate both intestinal and organ-specific inflammatory response.

    SCFA

    In the gut, non-digestible carbohydrates are transformed by the microbiota into SCFA such as acetate, propionate and butyrate[35]. Acetate and propionate are produced mainly byBacteroidetes, while butyrate, the main source of energy for colonocytes, byFirmicutes. A small portion of SCFA that is not metabolized can reach the liver through the portal vein, being used as energy substrates for hepatocytes[36 ,37]. Certain bacteria such asButyricimonasandPrevotellahave the ability to generate butyrate and propionate, SCFAs with anti-inflammatory effect[38].

    SCFA bind to the G-protein coupled free fatty acid receptors (FFA): GPR41 (FFA2 )and GPR43 (FFA3 )[39 ,40]. Enteroendocrine and pancreatic β-cells present both GPR41 and GPR43 receptors, while immune cells and adipocytes present mostly GPR41 and peripheral neurons GPR43 [41]. This links SCFA production to a multitude of metabolic, neurological and inflammatory mechanisms. Thus, FFA receptors and SCFA production presents therapeutic targets in these diseases[41 -43].

    In immune cells (leukocytes and neutrophils) SCFA increase the intracellular calcium levels[39 ,44 ,45]. This reaction leads to an increased production of reactive oxygen species, as well as an increased neutrophil recruitment and a pro-inflammatory effect[46 -48]. GPR41 activation by SCFAs in the gut promotes the function and size of regulatory T cells, protecting against intestinal inflammation[49]. Also, GPR43 was found to be a chemotactic receptor for neutrophils, stimulating their migration towards the source of SCFAs[50 ,51]. In a mouse model of gout, the intestinal microbiota-produced SCFA determined inflammasome assembly, reactive oxygen species formation and IL-1 b production and improved the inflammatory response[52].Increased SCFA levels determined the production of macrophages and dendritic cells,protecting the lung against allergic inflammation[53]. Also, by activating another Gprotein coupled receptor, GPR109 A, the microbiota is involved in inflammatory suppressionviathe NF-κB pathway in normal and colon cancer cells[54].

    Figure 1 The mechanisms by which the gut microbiome influences the immune system. LPS: Lipopolysaccharides; SCFA: Short-chain fatty acids.

    Another SCFA mechanism involved the inhibition of histone deacetylases (HDAC).By non-competitively inhibiting the activity of HDAC 1 and 2 , butyrate causes histone hyperacetylation. By this mechanism, butyrate and other SCFAs are thought to serve as a protective factor against colon cancer, dysbiosis being a risk factor for the development of this disease, as well as other chronic inflammatory diseases[55].HDAC inhibition also promotes macrophage activity and CD8 T cells and improves anti-cancer therapy[56 -59]. Furthermore, class 1 HDACs inhibition is proposed as a target in pulmonary inflammation, due to its contribution in the release of pro-inflammatory cytokines[60]. HDAC inhibition promotes effector and regulatory T-cell differentiation and the production of IL-17 , interferon-γ (IFN-γ) and IL-10 , contributing to an overall anti-inflammatory effect mediated by SCFAs[61 ,62].

    By increasing acetyl-CoA activity and controlling gene expression, SCFA are involved in plasma B cells metabolism, activity, energy production boosting, and differentiation. During an infection, they support B cells antibody production,decreasing the host susceptibility to pathogens[63].

    Therefore, SCFA present both a pro- and anti-inflammatory role[61]. There is still the need for more studies to fully understand the implications of SCFA in inflammatory and immune diseases and determine in which conditions they act as proinflammatory or as anti-inflammatory factors.

    Trp

    The microbiota is involved in the transformation of Trp in indole derivatives,serotonin (5 -hydroxytryptamine) and kynurenine[64].

    Lactobacilli species can metabolize Trp into indole-3 -aldehyde, a ligand for the aryl hydrocarbon receptor (AhR) that is involved in intestinal immunity and the production of IL-22 [65 ,66]. There are only a few species such asPeptostreptococcus russelliiandLactobacillus spp.with the ability to produce AhR ligands[64]. In high fat diets IL-22 can act as an antioxidant and anti-inflammatory agent, protecting the intestinal mucosa and epithelial cells from oxidative and inflammatory stressors[67].Also, IL-22 is involved in the intestinal mucosa immune response against exterior pathogens[68 ,69]. However, in patients with inflammatory bowel disease, Il-22 is considered a “two-headed cytokine”: it acts as a mucosal producing and healing agent,but in the chronic form of the disease it is also involved in tumorigenesis, promoting tumoral growth[70 -72].

    The Trp microbiota metabolite AhR regulates the activation and transcription of several other pathways, including IL-6 , cytochrome P4501 A1 (CYP1 A1 ), and 1 B1 (CYP1 B1 ), vascular endothelial growth factor A, and prostaglandin G/H synthase 2 and also stimulates innate lymphoid cells and intraepithelial lymphocytes development, mediating their anti-inflammatory effects[73 ,74]. Other bacteria that interfere with Trp metabolism areE. coli,LactobacilliandClostridium sporogenes. The first two possess tryptophanase which converts Trp to indole, while the latter decarboxylates Trp and increases tryptamine production[64].

    The microbiota influence on Trp provides intestinal anti-inflammatory effects, but it also poses potential research directions regarding systemic inflammation[75 ,76].

    Flagellin

    The locomotive bacterial flagella contain flagellin, which is recognized by the host TLR5 . Via the TLR pathways, flagellin is involved in several immunological mechanisms, both locally, in the gut, but also systemic, inducing the release of proinflammatory molecules[77]. In a study administering purified flagellin in mice, there was a decreased microbial dysbiosis, as well as an amelioration of IL-10 deficiencyinduced colitis[78]. This shows that flagellin presenting bacterial species could pose a beneficial effect in chronic inflammatory diseases. However, in patients with inflammatory bowel diseases there have been observed higher concentrations of flagellin,putting into question its supposed protective role[79]. Also, flagellin has been observed to be a potent TLR5 /NF-κB activator, promoting inflammation in intestinal epithelial cells[80]. Via the same TLR5 /NF-κB mechanism, flagellin could also promote the attachment and development of viral molecules, supporting viral infectionsviathe intestine[81].

    Bacterial CpG motifs

    Bacterial DNA contains unmethylated CpG dinucleotides that are recognized by the immune system and produce an immunostimulatory effect[82 ,83]. These bacterial CpG motifs are recognized by TLR9 receptors and, depending on their localization, they exhibit several effects. Apical TLR9 activation inhibits NF-κB activation, while basolateral receptors stimulate NF-κB activation and the subsequent inflammatory pathways[84].

    INFLAMMATION AND B AND C HEPATITIS

    Many extrahepatic changes (metabolic, cardiovascular, autoimmune, renal) have been correlated with chronic HCV infection. This statement is supported by a prospective cohort study in which patients with chronic HCV infection (with HCV RNA detected in the serum) had a high risk of death due to liver or non-liver disease (cardiovascular and renal disease) compared to uninfected patients (without serum HCV RNA) or with patients presenting HCV antibodies[85].

    Inflammatory cytokines are normally released in response to various stimuli,including viral infection. This limits cellular stress and cell damage[86]. HCV infection is associated with an immune activation status that can further influence the levels of inflammatory markers (Il-6 , TNF-α, iNOS, COX-2 , IL-1 ), which are correlated with various extrahepatic diseases[87 ,88]. In HBV-infected patients there is an increase in Il-8 , IL-29 and COX-2 . Under normal conditions, adult hepatocytes do not express COX-2 , but in chronic inflammatory diseases, the expression of this isoenzyme increases.Furthermore, IL-8 activates the extracellular signal-regulated kinase and c-Jun Nterminal kinase signaling pathways, which are also involved in inflammatory processes[86].

    In infected hepatocytes with HCV, the production of type 1 and 3 interferons is blocked by the action of the viral NS3 /4 A protease. This protease may also influence the innate immune adaptor molecules mitochondrial antiviral signaling proteins with an effect on the intracellular antiviral defense system. In an experimental study on hepatic macrophages the first activated factor in liver macrophages with HCV infection has been shown to be TNF-α that further activates NF-κB and increases IL-1 β.Adding to this, the HCV core protein also activates the NLRP3 inflammasome. The hepatic inflammatory environment is ensured by the activity of the NLRP3 inflammasome, phospholipase-C and IL-1 β. Thus, NLRP3 inflammasome and IL-1 β can be considered as target of treatment in HCV-induced liver disease[89].

    THE GUT-LIVER AXIS

    The gut microbiome can interact tightly with the liverviathe so-called gut-liver axis.Blood from the intestine, rich in microbiota-derived molecules, reaches the liverviathe portal vein. In the liver, these molecules are recognized by TLRs pattern recognition receptors, mediating their effect on the liver tissue[90]. Related to liver pathologies, the gut microbiota is particularly involved in liver fibrosis and cirrhosis, hepatic cancers,alcoholic and non-alcoholic fatty liver disease, autoimmune hepatitis, primary sclerosing and primary biliary cholangitis as well as viral hepatitis[91 -96]. Some of the most studied components that affect liver pathologies are represented by LPS and SCFAs.

    LPS produced by the microbiota are scarcely found in the normal liver, being cleared by Kupffer cells and not causing any damage[97]. However, in alcoholic liver disease, because of an increase intestinal permeability, an increased amount of LPS reached the liver[96]. LPS binds to TLR4 , causing an excessive release of pro-inflammatory cytokines IL-1 and TNF-α[33 ,98]. Also, LPS can upregulate the expression of the cluster of differentiation 14 (CD14 ) receptor on Kupffer cells[99]. This could potentially make the liver more sensitive to LPS toxicity, as CD14 is vital for Kupffer cells LPS activation[100]. Kupffer cells activation produces a pro-inflammatory state,increasing the levels of NF-κB, TNF-α and IL-1 . This leads to liver injury and disease progression, dysbiosis favoring the chronic inflammatory state[101].

    SCFA such as acetate, propionate and butyrate may have a protective effect on liver diseases progression. High levels of butyrate restore the intestinal microbiota in cases of dysbiosis, reducing the intestinal permeability and thus the levels of endotoxins reaching the liverviathe portal circulation. This attenuated the histological aspect of steatohepatitis livers, reducing the levels of TNF-α, IL-1 , IL-6 and IFN-γ pro-inflammatory cytokines, as well as the expression of TLR4 receptors[102]. In an experimental study by Endoet al[103], administering probiotics, aimed at increasing butyrate levels,significantly improved non-alcoholic fatty liver disease progression, reducing the inflammation and oxidative stress. This clearly shows that intestinal-produced metabolites can influence the immune and inflammatory state of the liver. Dysbiosis and an increased intestinal permeability allows for the gut-liver balance to change,causing a pro-inflammatory state of the liver and contributing to disease progression[104 ,105]. Pathogen-associated molecular patterns (bacterial antigens and products)such as LPS and viral RNAs activate TLR4 on Kupffer cells and other immune cells.Thus, the innate immune response is induced.

    The liver is influenced by the intestine through the portal circulation, while the intestine is influenced by the liver through the released mediators and hepatic bile flow. It is known that increased intestinal permeability contributes to systemic inflammation and disease progression[106]. BA and other mediators such as immunoglobulin A (IgA) regulate the gut-liver axis. IgA influences the homeostasis of the intestinal microbiota, preventing bacterial translocation. BA modulate the intestinal barrier and have antimicrobial activity. Several enzymes involved in BA synthesis are regulated by the microbiota. However, some secondary BA (e.g., deoxycholic acid)resulting from intestinal biotransformation produce microbial dysbiosis and increase the intestinal permeability[107].

    TGR5 is a G-protein-coupled BA receptor involved in the anti-inflammatory immune response, energy homeostasis, metabolic pathways and in pathologies such as diabetes and obesity[108]. In the intestine, TGR5 is involved in regulating the colonic motility and the intestinal permeabilityviathe farnesoid X receptor — cAMP pathway[109 ,110]. Moreover, TGR5 activation stimulates mucosal proliferation and protects against mucosal injuries[111]. In liver pathologies, the levels of BA are significantly decreased, leading to a reduced activation of TGR5 in the gut[112 ,113]. In a mouse model with TGR5 silencing, there was a significant reduction in gut epithelial cellularity, with histological abnormalities and distortions and an increased intestinal permeability[114]. BA and TGR5 activation are therefore necessary for a normal functioning of the intestine and the gut-blood barrier. BA administration is beneficial for viral hepatic diseases. In a HBV model, TGR5 agonists administration suppressed the infection[115]. BA and TGR5 agonists pose as potential treatment options for viral hepatitis[116].

    Decreased BA quantities in virus hepatitis could be responsible for the increased intestinal permeability and the subsequent increase in LPS and other endotoxins. This in turn favors the progression of the liver pathology, creating a vicious circle where the liver pathology creates an environment that further promotes the liver pathology(Figure 2 ). Future studies should determine the exact mechanism by which liver diseases influence the intestinal permeability and lead to the production of dysbiosis.

    THE GUT MICROBIOTA-VIRAL B AND C HEPATITIS

    The presence of the HBV or HCV infection can lead to intestinal dysbiosis[117]. Some of the microbial changes present in patients with HBV and HCV-related liver diseases are shown in Table 1 .

    Figure 2 The gut-liver axis in liver diseases. TGR5 : G-protein-coupled bile acid receptor; PAMPs: Pathogen-associated molecular patterns; LPS:Lipopolysaccharides; TLR: Toll-like receptor.

    These studies showed significant differences in the composition of the intestinal microbiota between patients with B or C hepatitis with or without cirrhosis present. A healthy gut microbiota means a gut microbiota with great diversity and the ability to react to changes. Thus, B and C viruses can cause changes and can shape the gut microbiota in different directions[122].

    Nowadays, the treatment of B and C hepatitis is well established by international guidelines[124 -126]. The main question is: does the treatment of B or C hepatitis influence the diversity and abundance of the intestinal microbiota? And if so, are these changes helping in preventing or halting the evolution of the disease? A part of the studies looking into the microbial changes caused by HBV and HCV treatments are presented in Table 2 .

    Entecavir increases the abundance of the genusClostridium sensu stricto 1which has been associated with large and extra-large HDL particles and also with a decreased risk of cardiovascular disease[131]. Increased lipid content in the liver and steatosis can result in the development of inflammation and, over time, cirrhosis, and can also increase oxidative stress[132]. GenusIntestinibacteralong with genusEscherichia,Shigellacan be considered as a major contributor to NAFLD progression. Increases in the abundance ofIntestinibacterhave been correlated with severe intestinal disorders in humans and are recognized as a biomarker of the onset of Crohn's disease[133].

    In a study by Pérez-Matuteet al[129], it was shown that the use of direct antiviral agents in patients with chronic HCV infection could only restore the intestinal bacterial changes in those patients with a lower degree of fibrosis (F0 -1 ). The data highlight a strong relationship between the liver and the intestine and suggest that mild intestinal changes caused by liver damage could possibly be counteracted with the appropriate drugs.

    Blautia, Coprococcus, Dorea, Lachnospira, Oribacterium, Roseburiaand L-Ruminococcuswere detected in the human intestine as the main genera belonging to theLachnospiraceaefamily[134].Lachnospiraceaeis considered a "good" family of bacteria, having a beneficial role in host homeostasis. The bacteria belonging to this family can convert carbohydrates into SCFA in the gut[135]. Decreasing the abundance ofLachnospiraceaeleads to decreased SCFA production and thus increases the pH of the colon. This change increases the production of ammonia and its absorption in the intestine[136].

    Direct-acting antivirals (DAA) treatment in cirrhotic patients appears to have a positive impact on changes in the intestinal microbiota, as well as fibrosis and inflammation, but without a positive impact on the function of the intestinal barrier. DAA has greatly reduced the abundance ofEnterobacteriaceae, Staphylococcus, andVeillonellaceae[130]. The abundance of theEnterobacteriaceaefamily, belonging to theProteobacteriaphylum, depends on the amount of oxygen that crosses the intestinal barrier.The abundance ofEnterobacteriaceaeis elevated after the oxygen level increases and can aggravate intestinal inflammation. Members of this family cannot degrade complex carbohydrates (asClostridiaandBacteroidiado); they are only involved in the passive transport of oligosaccharides. This disadvantage may explain the lower abundance ofEnterobacteriaceaecompared toClostridiaandBacteroidiain the healthy distal intestine[137].Veillonellaceaebelonging toFirmicutesphylum, is one of the main microbial taxaassociated with the severity of fibrosis in non-obese patients. This family has the ability to produce propionate, one of the most important SCFAs and has been associated with chronic liver disease[138]. The LPS and SCFA metabolites produced by intestinalVeillonellastimulate the release of cytokines (Il-6 , IL-10 , TNF-α) in human peripheral blood mononuclear cells and thus have a negative impact on liver pathology and host inflammation[139].

    Table 1 Microbiota changes in different studies regarding hepatic B and C virus

    Table 2 Microbial changes as a result of several treatments in viral B and C hepatitis

    GUT MICROBIOTA-TARGET OF TREATMENT

    Although standard therapy for B and C viral hepatitis is well established and presented in clinical guidelines, many dietary supplements, including pre-, pro-, and symbiotic agents, are being studied to reduce the toxicity of standard therapy (side effects) or to increase their effect. Also, fecal microbiota transplantation (FMT) is one of the methods that can manipulate the composition of the intestinal microbiota. It has the ability to strengthen the intestinal barrier, reduce intestinal permeability and also improve host immunity[140]. There are various routes of administration for FMT:nasogastric tube, upper endoscopy or colonoscopy, retention enema,etc.The route of administration depends on the characteristics of the disease. For example, good results have been obtained after duodenal administration in metabolic disease[141].

    There are only a few studies that support the effect of certain probiotics in viral B or C hepatitis.

    Ooet al[142] studied the long-term (36 -mo) effect of probiotic heat-treated strain Enterococcus faecalis FK-23 in patients with HCV infection. This probiotic may change the microbiota in these patients and may have an important role of decreased ALT in serum.

    In patients with HBV-induced liver cirrhosis, the role of a probiotic (Clostridium butyricumcombined withBifidobacterium infantis) has been studied in the treatment of minimal hepatic encephalopathy. The results claim that the probiotic modulates the intestinal barrier and thus can lower the level of ammonia and can improve cognition[143].

    CONCLUSION

    Most of the microbiota-derived components elicit an immunomodulatory effect, both pro- and anti-inflammatory. Alteration of the host microbiome produces an unbalance of these factors, leading to negative effects both locally in the intestine, as well as at distance in other organs. Therefore, we can conclude that by its factors, the host microbiota is an important determinant in the hosts immune response modulation.Future experimental and clinical studies are needed to determine the exact mechanisms of these changes, as well as the exact conditions in which the microbiota can serve as a protective factor.

    Currently, the intestinal microbiota is a target of treatment for various diseases in humans. Future studies should focus on the effects and efficacy of treatments aimed at restoring the gut microbial environment (prebiotics, probiotics, symbiotics, fecal transplant) and their exact relationship with liver pathologies. By understanding the natural communication pathways between the liver and the gut, in both health and disease, we could potentially formulate better therapies aimed at reducing the effects of the chronic inflammatory response on the progression of liver diseases.

    国产成人精品久久久久久| 日本-黄色视频高清免费观看| 日韩一区二区视频免费看| 韩国av在线不卡| 天天躁日日操中文字幕| 亚洲av免费在线观看| 亚洲精品日韩av片在线观看| 大又大粗又爽又黄少妇毛片口| 特大巨黑吊av在线直播| 国内精品宾馆在线| 一级毛片久久久久久久久女| 日本色播在线视频| 在线观看av片永久免费下载| 国产精品乱码一区二三区的特点| 一本精品99久久精品77| 91精品国产九色| 久久久久国内视频| 亚洲av第一区精品v没综合| 亚洲熟妇熟女久久| 国产探花在线观看一区二区| 欧美xxxx黑人xx丫x性爽| 国产精品日韩av在线免费观看| 日韩欧美三级三区| 久久久久久久久久黄片| 国产 一区精品| av在线观看视频网站免费| 日本-黄色视频高清免费观看| 寂寞人妻少妇视频99o| 精品少妇黑人巨大在线播放 | 男女啪啪激烈高潮av片| 日韩在线高清观看一区二区三区| av黄色大香蕉| 性插视频无遮挡在线免费观看| 日日干狠狠操夜夜爽| 成人特级av手机在线观看| 最好的美女福利视频网| 色哟哟哟哟哟哟| ponron亚洲| 午夜福利在线观看免费完整高清在 | 亚洲七黄色美女视频| 一夜夜www| 久久婷婷人人爽人人干人人爱| 亚洲第一区二区三区不卡| 国内精品久久久久精免费| 欧美另类亚洲清纯唯美| 精品99又大又爽又粗少妇毛片| 麻豆国产av国片精品| 国模一区二区三区四区视频| 床上黄色一级片| 精品久久久久久久久av| 少妇人妻一区二区三区视频| 国产视频一区二区在线看| 免费人成在线观看视频色| 成人综合一区亚洲| 亚洲精品乱码久久久v下载方式| 国产中年淑女户外野战色| 精品免费久久久久久久清纯| 日韩强制内射视频| 久久精品国产自在天天线| 国产亚洲精品av在线| 又黄又爽又刺激的免费视频.| 日本三级黄在线观看| 日本撒尿小便嘘嘘汇集6| 高清毛片免费观看视频网站| 女人十人毛片免费观看3o分钟| АⅤ资源中文在线天堂| 九九久久精品国产亚洲av麻豆| 亚洲成人中文字幕在线播放| 日本与韩国留学比较| 亚洲成人av在线免费| 可以在线观看毛片的网站| 最新在线观看一区二区三区| 久久久久九九精品影院| 久久久久久久久久黄片| 午夜福利在线在线| 国产成人精品久久久久久| 精品久久久久久久人妻蜜臀av| 亚洲天堂国产精品一区在线| 精品午夜福利视频在线观看一区| 在线观看午夜福利视频| 岛国在线免费视频观看| 男女之事视频高清在线观看| 国产一区二区在线观看日韩| 99久久久亚洲精品蜜臀av| 国产精品1区2区在线观看.| 欧美高清性xxxxhd video| 久久精品国产亚洲av天美| 麻豆国产av国片精品| 麻豆av噜噜一区二区三区| 久久久国产成人精品二区| 国产精品久久久久久久久免| 日韩 亚洲 欧美在线| 99久国产av精品国产电影| 久久久色成人| 中文字幕精品亚洲无线码一区| 国产成人a∨麻豆精品| 免费高清视频大片| 日韩制服骚丝袜av| 日本与韩国留学比较| av在线观看视频网站免费| 日韩中字成人| 天天躁夜夜躁狠狠久久av| 精品熟女少妇av免费看| 亚洲电影在线观看av| 亚洲av五月六月丁香网| 免费观看精品视频网站| 成人性生交大片免费视频hd| 少妇猛男粗大的猛烈进出视频 | 国产aⅴ精品一区二区三区波| 秋霞在线观看毛片| а√天堂www在线а√下载| 偷拍熟女少妇极品色| а√天堂www在线а√下载| 日本爱情动作片www.在线观看 | 日本撒尿小便嘘嘘汇集6| 1024手机看黄色片| 国产成人a∨麻豆精品| 卡戴珊不雅视频在线播放| 久久午夜福利片| 91在线精品国自产拍蜜月| 有码 亚洲区| 99久久中文字幕三级久久日本| 亚洲乱码一区二区免费版| ponron亚洲| 国产免费一级a男人的天堂| 中文亚洲av片在线观看爽| 久久久午夜欧美精品| 亚洲精品日韩在线中文字幕 | 久久亚洲国产成人精品v| 不卡视频在线观看欧美| 婷婷亚洲欧美| 欧美+日韩+精品| 亚洲经典国产精华液单| 91在线观看av| 精品久久久久久久人妻蜜臀av| 真人做人爱边吃奶动态| 亚洲人成网站在线观看播放| 中文字幕久久专区| 99热这里只有是精品50| 天堂网av新在线| 亚洲成av人片在线播放无| 婷婷亚洲欧美| 身体一侧抽搐| 老熟妇仑乱视频hdxx| 日本黄色视频三级网站网址| 国产一级毛片七仙女欲春2| 午夜福利高清视频| 欧美一区二区精品小视频在线| 村上凉子中文字幕在线| 三级国产精品欧美在线观看| 精品一区二区三区人妻视频| 中文字幕av成人在线电影| 波多野结衣高清无吗| 人人妻人人澡欧美一区二区| 国产精品国产三级国产av玫瑰| 深爱激情五月婷婷| 午夜免费激情av| 亚洲av免费高清在线观看| 三级毛片av免费| 夜夜夜夜夜久久久久| 精品久久久久久成人av| 丝袜喷水一区| 麻豆一二三区av精品| 久久久久国产网址| 不卡一级毛片| 久久精品久久久久久噜噜老黄 | 99久国产av精品| 亚洲人成网站在线播| 日韩一区二区视频免费看| 波野结衣二区三区在线| 人人妻人人澡欧美一区二区| 亚洲av免费在线观看| 美女内射精品一级片tv| 在线看三级毛片| 男女那种视频在线观看| 黄色一级大片看看| 亚洲激情五月婷婷啪啪| eeuss影院久久| 免费高清视频大片| 女人十人毛片免费观看3o分钟| 简卡轻食公司| 亚洲精品乱码久久久v下载方式| 美女被艹到高潮喷水动态| 看黄色毛片网站| 婷婷亚洲欧美| 一进一出抽搐gif免费好疼| 日韩中字成人| 亚洲av一区综合| 高清毛片免费观看视频网站| 久久草成人影院| 99久久成人亚洲精品观看| 国产精品不卡视频一区二区| 日韩精品中文字幕看吧| 国产精品久久久久久久电影| 精华霜和精华液先用哪个| 国产欧美日韩精品亚洲av| 嫩草影院入口| 一本久久中文字幕| 99热全是精品| 亚洲第一电影网av| 可以在线观看毛片的网站| 中国美白少妇内射xxxbb| 亚洲中文字幕一区二区三区有码在线看| 国产免费一级a男人的天堂| 国产av在哪里看| 日韩欧美三级三区| 日韩精品有码人妻一区| 97在线视频观看| 三级毛片av免费| 久久久久久久久中文| 人人妻人人澡人人爽人人夜夜 | 日韩欧美国产在线观看| 国产综合懂色| 97超碰精品成人国产| 看十八女毛片水多多多| 99久久久亚洲精品蜜臀av| 久久人人精品亚洲av| 久久国产乱子免费精品| 亚洲最大成人av| videossex国产| 久久精品夜色国产| 欧美另类亚洲清纯唯美| 久久人妻av系列| 久久亚洲国产成人精品v| 少妇熟女aⅴ在线视频| 成人亚洲欧美一区二区av| 97碰自拍视频| www.色视频.com| 成人漫画全彩无遮挡| 在线观看午夜福利视频| 免费在线观看成人毛片| 亚洲天堂国产精品一区在线| 在线播放无遮挡| 黄色一级大片看看| 一区二区三区高清视频在线| 在线观看一区二区三区| 国产av不卡久久| 亚洲高清免费不卡视频| 亚洲精品456在线播放app| 精品人妻一区二区三区麻豆 | 欧美+亚洲+日韩+国产| 久久国产乱子免费精品| 国产一区二区激情短视频| 在线观看午夜福利视频| 99热这里只有精品一区| 成人永久免费在线观看视频| 成人毛片a级毛片在线播放| 久久国产乱子免费精品| 国产一区二区激情短视频| 日韩欧美精品免费久久| 国内久久婷婷六月综合欲色啪| 亚洲av五月六月丁香网| 久久精品国产清高在天天线| 日本欧美国产在线视频| 别揉我奶头 嗯啊视频| 伊人久久精品亚洲午夜| 免费看a级黄色片| 床上黄色一级片| 久久国内精品自在自线图片| 老师上课跳d突然被开到最大视频| 亚洲最大成人中文| 12—13女人毛片做爰片一| 久久精品影院6| 国产真实乱freesex| 国产伦精品一区二区三区四那| 99久久久亚洲精品蜜臀av| 国产精品国产三级国产av玫瑰| 18禁在线无遮挡免费观看视频 | 天天躁夜夜躁狠狠久久av| 国产伦精品一区二区三区视频9| 超碰av人人做人人爽久久| 简卡轻食公司| 一级毛片aaaaaa免费看小| 女同久久另类99精品国产91| 日韩精品有码人妻一区| 搡老妇女老女人老熟妇| 国产亚洲欧美98| 小蜜桃在线观看免费完整版高清| 成年女人看的毛片在线观看| 日本 av在线| 免费人成视频x8x8入口观看| 老司机福利观看| 啦啦啦韩国在线观看视频| 不卡一级毛片| 精品久久久久久久久av| 亚洲四区av| 日本在线视频免费播放| 久久久久国产精品人妻aⅴ院| 此物有八面人人有两片| 99在线人妻在线中文字幕| 精品久久久久久久末码| 国产乱人偷精品视频| 三级国产精品欧美在线观看| 国产精品爽爽va在线观看网站| 国产中年淑女户外野战色| 亚洲丝袜综合中文字幕| 国产一级毛片七仙女欲春2| 亚州av有码| 亚洲成人久久爱视频| 亚洲无线观看免费| av天堂在线播放| 日日干狠狠操夜夜爽| 成年av动漫网址| 三级经典国产精品| АⅤ资源中文在线天堂| aaaaa片日本免费| 精品福利观看| 久久精品国产亚洲av香蕉五月| 亚洲精品久久国产高清桃花| 亚洲国产精品国产精品| 亚洲成人av在线免费| 日本精品一区二区三区蜜桃| 日韩亚洲欧美综合| 一级毛片aaaaaa免费看小| 中文字幕av成人在线电影| 国产一区二区三区在线臀色熟女| 国产日本99.免费观看| 久久久久免费精品人妻一区二区| av国产免费在线观看| 69av精品久久久久久| 久久久久久久久久久丰满| 成人特级黄色片久久久久久久| 波多野结衣高清作品| 午夜福利视频1000在线观看| 亚洲天堂国产精品一区在线| 中文亚洲av片在线观看爽| 99在线人妻在线中文字幕| 亚洲av中文av极速乱| 久久久久久久午夜电影| 可以在线观看的亚洲视频| 日韩成人伦理影院| 男人舔奶头视频| 国产精品女同一区二区软件| 校园春色视频在线观看| 三级男女做爰猛烈吃奶摸视频| 97在线视频观看| 欧美高清性xxxxhd video| 国产午夜福利久久久久久| 欧美精品国产亚洲| 免费在线观看成人毛片| 黄色一级大片看看| 国产精品一及| 亚洲欧美日韩高清专用| 欧美潮喷喷水| 午夜影院日韩av| 岛国在线免费视频观看| 午夜久久久久精精品| 免费观看在线日韩| 我的女老师完整版在线观看| 久久午夜亚洲精品久久| 啦啦啦韩国在线观看视频| av在线蜜桃| 波多野结衣高清作品| 午夜精品在线福利| 国产aⅴ精品一区二区三区波| 1000部很黄的大片| 国产精品女同一区二区软件| 欧洲精品卡2卡3卡4卡5卡区| 成人亚洲欧美一区二区av| 国产一区亚洲一区在线观看| 成人av在线播放网站| 免费一级毛片在线播放高清视频| 国产成人精品久久久久久| 99在线人妻在线中文字幕| 好男人在线观看高清免费视频| 淫妇啪啪啪对白视频| 91久久精品电影网| or卡值多少钱| 在线播放国产精品三级| .国产精品久久| АⅤ资源中文在线天堂| 在线免费观看不下载黄p国产| 欧美日本视频| 一级a爱片免费观看的视频| 日日干狠狠操夜夜爽| 亚洲人成网站在线播| 国产熟女欧美一区二区| 美女大奶头视频| 欧美激情在线99| 国产又黄又爽又无遮挡在线| 日本黄色视频三级网站网址| 国产一区二区激情短视频| 亚洲成a人片在线一区二区| 亚洲性久久影院| 色综合亚洲欧美另类图片| 亚洲最大成人手机在线| 男女那种视频在线观看| 国内少妇人妻偷人精品xxx网站| 成人特级av手机在线观看| aaaaa片日本免费| 国产精品乱码一区二三区的特点| av在线观看视频网站免费| АⅤ资源中文在线天堂| 国产真实乱freesex| 国产免费男女视频| 亚洲美女黄片视频| 日日摸夜夜添夜夜爱| 午夜久久久久精精品| 不卡一级毛片| a级毛片a级免费在线| 一卡2卡三卡四卡精品乱码亚洲| 你懂的网址亚洲精品在线观看 | 成熟少妇高潮喷水视频| 欧美激情国产日韩精品一区| 色噜噜av男人的天堂激情| 丝袜美腿在线中文| 国内精品久久久久精免费| 国产一区二区在线观看日韩| 夜夜夜夜夜久久久久| 永久网站在线| 乱人视频在线观看| 国产久久久一区二区三区| 国产三级中文精品| 一个人免费在线观看电影| 久久草成人影院| av.在线天堂| 美女xxoo啪啪120秒动态图| 一卡2卡三卡四卡精品乱码亚洲| 高清午夜精品一区二区三区 | 亚洲精品色激情综合| 国产麻豆成人av免费视频| 欧美日本视频| 菩萨蛮人人尽说江南好唐韦庄 | 真人做人爱边吃奶动态| 精品人妻视频免费看| 能在线免费观看的黄片| 久久久久国产精品人妻aⅴ院| 免费电影在线观看免费观看| 非洲黑人性xxxx精品又粗又长| 久久久久免费精品人妻一区二区| 国产高清激情床上av| 日本撒尿小便嘘嘘汇集6| 伊人久久精品亚洲午夜| 免费不卡的大黄色大毛片视频在线观看 | 人人妻人人澡欧美一区二区| 嫩草影院入口| 天堂av国产一区二区熟女人妻| 日韩制服骚丝袜av| 韩国av在线不卡| 在线观看66精品国产| 国国产精品蜜臀av免费| 极品教师在线视频| 国产亚洲精品久久久久久毛片| 91久久精品国产一区二区三区| 色尼玛亚洲综合影院| 精品人妻偷拍中文字幕| 两个人视频免费观看高清| 日韩大尺度精品在线看网址| 欧美日韩在线观看h| 国产亚洲av嫩草精品影院| 91在线观看av| 久久久久久久久大av| 少妇裸体淫交视频免费看高清| 91久久精品国产一区二区成人| 国产色婷婷99| www日本黄色视频网| 国产真实乱freesex| 高清午夜精品一区二区三区 | 少妇被粗大猛烈的视频| 成人无遮挡网站| 中文字幕av在线有码专区| 免费电影在线观看免费观看| 久久人人爽人人片av| 亚洲专区国产一区二区| 亚洲精品国产成人久久av| 亚洲第一电影网av| 亚洲精品在线观看二区| 精品久久久久久久末码| 少妇的逼水好多| 日韩欧美一区二区三区在线观看| 亚洲成人久久爱视频| 日本成人三级电影网站| 波多野结衣高清作品| 99久国产av精品| 欧美一区二区精品小视频在线| 日日干狠狠操夜夜爽| 可以在线观看毛片的网站| 深夜a级毛片| 亚洲欧美中文字幕日韩二区| 久久久久国产精品人妻aⅴ院| 国产一区二区亚洲精品在线观看| 精品日产1卡2卡| 不卡一级毛片| 久久6这里有精品| 赤兔流量卡办理| 九九久久精品国产亚洲av麻豆| 国产美女午夜福利| 在线观看免费视频日本深夜| 日日干狠狠操夜夜爽| 午夜视频国产福利| 国内揄拍国产精品人妻在线| 中文字幕精品亚洲无线码一区| av.在线天堂| 综合色丁香网| 99精品在免费线老司机午夜| 99久久精品热视频| 麻豆av噜噜一区二区三区| 1000部很黄的大片| 六月丁香七月| 一个人看视频在线观看www免费| 变态另类丝袜制服| 又爽又黄a免费视频| 日韩中字成人| 老司机福利观看| 精品国产三级普通话版| 啦啦啦啦在线视频资源| 日本与韩国留学比较| 免费看av在线观看网站| 午夜福利高清视频| 18禁裸乳无遮挡免费网站照片| 久久久久国产精品人妻aⅴ院| 舔av片在线| 成人欧美大片| 国产成年人精品一区二区| 国产av一区在线观看免费| 婷婷色综合大香蕉| 亚洲国产精品成人久久小说 | 亚洲经典国产精华液单| 美女xxoo啪啪120秒动态图| 91在线观看av| 床上黄色一级片| 又黄又爽又刺激的免费视频.| 日韩精品有码人妻一区| 国产麻豆成人av免费视频| 午夜福利在线观看免费完整高清在 | 亚洲精品日韩av片在线观看| 久久久久性生活片| 国产爱豆传媒在线观看| 久久久久九九精品影院| 国内精品一区二区在线观看| 免费观看人在逋| 日韩在线高清观看一区二区三区| 久久精品影院6| 亚洲在线观看片| 久久婷婷人人爽人人干人人爱| 特大巨黑吊av在线直播| 日本五十路高清| 亚洲欧美日韩高清专用| 成人亚洲欧美一区二区av| 亚洲aⅴ乱码一区二区在线播放| 中文资源天堂在线| 色综合站精品国产| 久久久精品大字幕| www.色视频.com| 老司机午夜福利在线观看视频| 日本与韩国留学比较| 一级黄片播放器| 男女啪啪激烈高潮av片| 久久午夜亚洲精品久久| 久久精品91蜜桃| 免费搜索国产男女视频| 国产精品不卡视频一区二区| 国产精品日韩av在线免费观看| 日韩大尺度精品在线看网址| 国产私拍福利视频在线观看| 欧美高清性xxxxhd video| www日本黄色视频网| 极品教师在线视频| 午夜影院日韩av| aaaaa片日本免费| av天堂在线播放| 亚洲成人久久爱视频| 精品一区二区三区视频在线观看免费| 最后的刺客免费高清国语| 一级黄色大片毛片| 欧美在线一区亚洲| 婷婷精品国产亚洲av| 欧美成人a在线观看| 一个人看的www免费观看视频| 日本爱情动作片www.在线观看 | 九色成人免费人妻av| 亚洲在线观看片| 美女黄网站色视频| 国产乱人偷精品视频| 高清日韩中文字幕在线| 乱码一卡2卡4卡精品| 香蕉av资源在线| 免费人成在线观看视频色| 亚洲最大成人av| 成年版毛片免费区| 国产精品久久久久久av不卡| 成年版毛片免费区| 丝袜美腿在线中文| 天天一区二区日本电影三级| 校园人妻丝袜中文字幕| 少妇熟女aⅴ在线视频| 成人午夜高清在线视频| 97超碰精品成人国产| av在线天堂中文字幕| 伦精品一区二区三区| 日本a在线网址| 黄色配什么色好看| 亚洲精品影视一区二区三区av| 在线观看66精品国产| 高清毛片免费观看视频网站| av福利片在线观看| 毛片一级片免费看久久久久| 免费观看在线日韩| 亚洲国产精品成人久久小说 | 国产老妇女一区| 51国产日韩欧美| 3wmmmm亚洲av在线观看| 国产色爽女视频免费观看| 女生性感内裤真人,穿戴方法视频| 久久久久久久久久成人| 欧美成人a在线观看| 身体一侧抽搐| 国产亚洲欧美98| 久久这里只有精品中国| 精品久久久噜噜| 中国国产av一级| 国产精品国产高清国产av| 亚洲va在线va天堂va国产| 在线观看av片永久免费下载| 国产精品伦人一区二区|